Compounds > lysine
Page last updated: 2024-08-17

lysine and Bowel Diseases, Inflammatory

lysine has been researched along with Bowel Diseases, Inflammatory in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Denning, TL; Gewirtz, AT; Gheinani, PT; Guan, X; Hou, Y; Jin, C; Li, C; Liu, Y; Naren, AP; Sharma, S; Sun, X; Xie, Z; Yang, Z; Yin, J; Zhou, Y1
de Graaf, MCG; Feskens, EJM; Jonkers, DMAE; Keszthelyi, D; Mujagic, Z; Pierik, MJ; Schalkwijk, CG; Scheijen, JLJM; Spooren, CEGM1
Goel, A; Jadhav, U; Lorzadeh, A; Romero-Wolf, M1
Hong, CO; Lee, KW; Pyo, MC; Rhee, CH1
Cao, N; Chen, M; Deng, Y; Li, L; Li, Q; Wu, M; Ye, M; Zhao, Q1
Andrassy, M; Autschbach, F; Bierhaus, A; Chen, J; Humpert, PM; Igwe, J; Katus, HA; Kientsch-Engel, R; Liliensiek, B; Morcos, M; Nawroth, PP; Neurath, MF; Remppis, A; Schiekofer, S; Schleicher, E; Schmidt, AM; Stern, DM; Stremmel, W; Thiele, K; Volz, C; Wendt, T1
Ansorge, S; Bank, U; Faust, J; Fuchs, P; Heimburg, A; Helmuth, M; Lendeckel, U; Neubert, K; Reinhold, D; Sens, B; Stefin, S; Täger, M1

Reviews

1 review(s) available for lysine and Bowel Diseases, Inflammatory

ArticleYear
Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.
    Gastroenterology, 2021, Volume: 160, Issue:7

    Topics: Chromatin; DNA Methylation; Epigenesis, Genetic; Gastrointestinal Neoplasms; Histones; Humans; Inflammatory Bowel Diseases; Lysine; Polycomb Repressive Complex 2; Protein Processing, Post-Translational; Stem Cells

2021

Other Studies

6 other study(ies) available for lysine and Bowel Diseases, Inflammatory

ArticleYear
Epithelial SMYD5 Exaggerates IBD by Down-regulating Mitochondrial Functions via Post-Translational Control of PGC-1α Stability.
    Cellular and molecular gastroenterology and hepatology, 2022, Volume: 14, Issue:2

    Topics: Animals; Colitis; Dextran Sulfate; Humans; Inflammatory Bowel Diseases; Lysine; Mice; Mitochondria

2022
The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
    Nutrients, 2022, Dec-24, Volume: 15, Issue:1

    Topics: Diet; Glycation End Products, Advanced; Humans; Inflammation; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Lysine; Pyruvaldehyde

2022
Anti-inflammatory effect of glucose-lysine Maillard reaction products on intestinal inflammation model in vivo.
    International immunopharmacology, 2017, Volume: 52

    Topics: Animals; Anti-Inflammatory Agents; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; Glucose; Glycation End Products, Advanced; Humans; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Intestines; Lipid Peroxidation; Lysine; Male; Rats; Rats, Wistar

2017
Profiling of histone 3 lysine 27 acetylation reveals its role in a chronic DSS-induced colitis mouse model.
    Molecular omics, 2019, 08-05, Volume: 15, Issue:4

    Topics: Acetylation; Animals; Chromatin Immunoprecipitation Sequencing; Colitis; Dextran Sulfate; Disease Models, Animal; Enhancer Elements, Genetic; Epigenesis, Genetic; Histones; Inflammation; Inflammatory Bowel Diseases; Lysine; Male; Mice; Mice, Inbred C57BL; RNA-Seq; Transcription Factors; Up-Regulation

2019
Posttranslationally modified proteins as mediators of sustained intestinal inflammation.
    The American journal of pathology, 2006, Volume: 169, Issue:4

    Topics: Adult; Animals; Calgranulin A; Calgranulin B; Cell Extracts; Disease Models, Animal; Endothelial Cells; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Lysine; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Receptor for Advanced Glycation End Products; Receptors, Immunologic

2006
Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
    International immunopharmacology, 2006, Dec-20, Volume: 6, Issue:13-14

    Topics: Animals; Body Weight; CD13 Antigens; Colitis; Colon; Cytokines; Dextran Sulfate; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Forkhead Transcription Factors; Gene Expression; Hydroxamic Acids; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lysine; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta

2006